Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

FDA approves Scynexis’ Brexafemme for recurrent vulvovaginal candidiasis

The antifungal is already approved in the US for vulvovaginal candidiasis

How to Increase Engagement During Virtual Events

Tip #2 - Are you team ""jump on a call"" or team ""just email me""? Instead of choosing just one, try using a combination of synchronous (real-time) and asynchronous (over-time,...

Impetus Digital

- PMLiVE

Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk

The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors

- PMLiVE

WHO calls for leaders to address the global HIV response

Its key focus is to highlight inequalities that hinder progress in the goal to end AIDS by 2030

- PMLiVE

Lilly’s donanemab shows promise in early symptomatic Alzheimer’s comparator study

Brain amyloid clearance was achieved in 37.9% of patients treated with the investigational antibody

- PMLiVE

BioNTech and Ryvu partner to develop immuno-modulatory small molecule candidates

The focus will be on immune modulation within oncology and potentially other disease areas

- PMLiVE

bluebird bio sells Rare Pediatric Disease Priority Review Voucher

The company was granted two PRVs upon the FDA approvals of Zynteglo and Skysona

- PMLiVE

Scientists identify vital role of enzyme in survival of certain cancers

The results offer the foundations for a clinical trial evaluating the effects of POLQ inhibitors

- PMLiVE

FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

Origins announces the first speaker on the panel of our upcoming webinar

Origins – The Patient Focused Specialists

- PMLiVE

Concerns about data security are building a strong case for clinical mobility in EMEA

Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?

Biogen Idec building

Biogen and Eisai’s Alzheimer’s drug shown to slow memory decline in confirmatory study

The findings have been described as a ‘major step forward’ for dementia research

- PMLiVE

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

After changing to Biktarvy, 98% of patients in two groups were suppressed at week 48

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links